Sentence examples for marker of benign from inspiring English sources

Clinical and behavioural differences between patients with tremor-dominant and non-tremor Parkinson's disease suggest that tremor is a marker of benign Parkinson's disease.

18– 24 The enzyme thyroid peroxidase (TPO) appears to be changed early in malignant transformation, and it has been discussed whether this enzyme might be a marker of benign vs. malignant thyroid lesions.

After post-processing, using commercially available software packages, spectral information is overlaid on T2WIs.The relevant metabolites are citrate (marker of benign tissue), creatine (insignificant for diagnosis, but difficult to resolve from choline), and choline (marker of malignant tissue).

1, 3, 5 The aim was to reduce the number of unnecessary surgical thyroid resections, and TPO immunostaining, which had previously proven to be an excellent marker of benign vs. malignant lesions in optimally handled FNACs, 31 was used systematically as an adjunct to morphology.

The main metabolites in the prostate gland are citrate (Cit, a marker of benign tissue), creatinine (Cr, insignificant for diagnosis, but difficult to resolve from choline), and choline (Cho, involved in the cellular membrane synthesis and degradation, a marker of malignant tissue).

Studies in varied settings have provided estimates of the prevalence of surrogate markers of benign prostatic hyperplasia (BPH).

Mammographic MCs serve as important diagnostic markers of benign and malignant breast lesions.

In this study, we determined the prognostic significance in prostate cancer of two novel markers of benign prostate basal cells.

However, in many of these studies, LUTS was defined as including diagnoses or markers of benign prostatic hyperplasia and were limited by the inclusion of a relatively small sample of diabetic men.

Therefore, detection of a PDGFRA mutation in gastric GISTs may represent an additional prognostic marker of more benign tumour behaviour.

These findings reveal a novel role for HDAC1 in the control of tumour proliferation and identify HDAC1 as potential marker for benign teratomas.